STRAIN-SPECIFIC EFFECTS OF PROBIOTICS IN GASTROESOPHAGEAL REFLUX DISEASE: A COMPREHENSIVE REVIEW

Izabela Kazubek-Fuksiewicz; Magdalena Kossmann; Amin Abdulgater; Paulina Osuch-Tomaszewska; Wiktoria Urowska; Laura Szalewska; Julia Burtowicz; Jędrzej Łysiak; Beniamin Pior Rembowski

doi:10.31435/ijitss.3(51).2026.6252

Authors

Izabela Kazubek-Fuksiewicz Medical University of Silesia, Katowice, Poland https://orcid.org/0009-0000-4433-2638
Magdalena Kossmann St. Vincent de Paul Hospital, Gdynia, Poland https://orcid.org/0009-0003-2822-6669
Amin Abdulgater University Clinical Hospital No. 2 PMU, Szczecin, Poland https://orcid.org/0009-0000-3782-5776
Paulina Osuch-Tomaszewska University Clinical Hospital No. 2, Szczecin, Poland https://orcid.org/0009-0002-4204-0273
Wiktoria Urowska St. Vincent de Paul Hospital, Gdynia, Poland https://orcid.org/0009-0000-4167-4798
Laura Szalewska University Clinical Hospital No. 2, Szczecin, Poland https://orcid.org/0000-0002-9529-7593
Julia Burtowicz Collegium Medicum Nicolaus Copernicus University in Bydgoszcz https://orcid.org/0009-0004-5598-4833
Jędrzej Łysiak University Clinical Hospital No. 2 PMU, Szczecin, Poland https://orcid.org/0009-0005-5798-3620
Beniamin Pior Rembowski Medical University of Silesia, Katowice, Poland https://orcid.org/0009-0007-1985-0389

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.6252

Keywords:

Gastroesophageal Reflux Disease (GERD), Probiotics, Lactobacillus reuteri, Lactobacillus rhamnosus GG, Bifidobacterium, Gut Microbiota, Esophageal Microbiota, Proton Pump Inhibitors (PPIs), Glucagon-Like Peptide-1 (GLP-1)

Abstract

Gastroesophageal reflux disease (GERD) is one of the most prevalent gastrointestinal disorders worldwide and represents a significant burden on healthcare systems due to its high prevalence, chronic course, and impact on patients’ quality of life. Although proton pump inhibitors (PPIs) remain the cornerstone of GERD treatment, a considerable proportion of patients continue to experience persistent symptoms, and concerns regarding the long-term use of acid-suppressive therapy have increased interest in complementary therapeutic approaches. Recent advances in microbiome research have highlighted the potential role of gut and esophageal microbiota in the pathogenesis of GERD, suggesting that probiotics may offer therapeutic benefits beyond conventional treatment. This review summarizes current evidence regarding the strain-specific effects of probiotics in GERD, focusing on commonly investigated strains, including Lactobacillus reuteri, Lactobacillus rhamnosus GG, Lactobacillus acidophilus, and Bifidobacterium species. Available studies indicate that these probiotics may improve upper gastrointestinal symptoms through modulation of the intestinal microbiota, enhancement of epithelial barrier function, regulation of inflammatory responses, and improvement of gastrointestinal motility. Emerging evidence also suggests that certain Bifidobacterium strains may indirectly influence glucagon-like peptide-1 (GLP-1) secretion via the production of short-chain fatty acids, although the clinical significance of this mechanism in GERD has not yet been established. Overall, current findings support the use of probiotics as a promising adjunct to standard GERD therapy; however, their effects remain highly strain-specific, and the available evidence is limited by heterogeneous study designs and relatively small patient populations. Further well-designed randomized controlled trials are required to determine the most effective probiotic strains, optimal treatment regimens, and their long-term role in the management of GERD.

References

Park, C. H., & Lee, S. K. (2020). Exploring esophageal microbiomes in esophageal diseases: A systematic review. Journal of Neurogastroenterology and Motility, 26(2), 171–179.

Zhang, X., Zhang, N., & Wang, Z. (2023). Esophageal microflora in esophageal diseases. Frontiers in Cellular and Infection Microbiology.

Zhang, X., Zhang, N., & Wang, Z. (2023). Eosinophilic esophagitis and esophageal microbiota. Frontiers in Cellular and Infection Microbiology.

The role of the esophageal and intestinal microbiome in gastroesophageal reflux disease: Past, present, and future. (2025). Frontiers in Microbiology.

Microbiome and cancers of the esophagus: A review. (2021). Cancers (Basel).

Rescigno, M. (2023). Microbiota in reflux esophagitis and peptic ulcer disease. Surgical Infections.

Cheng, J., & Ouwehand, A. C. (2020). Gastroesophageal reflux disease and probiotics: A systematic review. Nutrients, 12(1), 132.

Hungin, A. P. S., Mulligan, C., Pot, B., et al. (2013). Systematic review: Probiotics in the management of lower gastrointestinal symptoms. Aliment Pharmacol Ther, 38(8), 864–886.

Hill, C., Guarner, F., Reid, G., et al. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of probiotics. Nat Rev Gastroenterol Hepatol, 11(8), 506–514.

Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019). Probiotics and prebiotics in intestinal health and disease. Nat Rev Gastroenterol Hepatol, 16(10), 605–616.

Zhang, Y., et al. (2026). Adjunctive probiotic therapy sustains symptom relief in gastroesophageal reflux disease through gut microbiome-metabolome remodeling. mSystems.

Everard, A., & Cani, P. D. (2014). Gut microbiota and GLP-1. Reviews in Endocrine and Metabolic Disorders, 15(3), 189–196. https://doi.org/10.1007/s11154-014-9288-6

Greiner, T. U., & Bäckhed, F. (2016). Microbial regulation of GLP-1 and L-cell biology. Molecular Metabolism, 5(9), 753–758. https://doi.org/10.1016/j.molmet.2016.05.012

Everard, A., & Cani, P. D. (2014). Gut microbiota and GLP-1. Rev Endocr Metab Disord.

Greiner, T. U., & Bäckhed, F. (2016). Microbial regulation of GLP-1 and L-cell biology. Mol Metab.

Yadav, H., et al. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 secretion. J Biol Chem.

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., et al. (2019). The microbiota–gut–brain axis. Physiological Reviews.

Martin, A. M., Sun, E. W., Rogers, G. B., & Keating, D. J. (2019). The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Frontiers in Physiology.